Development and validation of the CAIL prognostic score in non‐small cell lung cancer patients with malignant pleural effusion

BACKGROUND: Patients with malignant pleural effusion (MPE) typically have poor prognoses, and predicting survival is challenging. The present study aimed to identify prognostic factors of overall survival (OS) in non‐small cell lung cancer (NSCLC) patients with MPE in the time of immunotherapy and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianyuan, Tian, Panwen, Huang, Qin, Zeng, Hao, Wei, Qi, Li, Yalun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632079/
https://www.ncbi.nlm.nih.gov/pubmed/37723659
http://dx.doi.org/10.1111/crj.13700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632079/
https://www.ncbi.nlm.nih.gov/pubmed/37723659
http://dx.doi.org/10.1111/crj.13700

Ejemplares similares